⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Steriscience and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Steriscience
↗Bengaluru, India
Steriscience is a specialized pharmaceutical company focused on the development and manufacturing of complex sterile injectables. The company operates as part of a broader group (associated with Strides Pharma Science) and has been undergoing a strategic restructuring to consolidate its CDMO operations into a new entity called OneSource.
The company maintains manufacturing capabilities in India and Poland, with facilities compliant with major global regulatory standards including the US FDA and EU GMP. Its product portfolio emphasizes high-quality, life-sustaining drugs, particularly in the carbapenem antibiotic segment and other complex injectable delivery platforms.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Revenue:$50M-$100M
Founded:2020
Ownership:subsidiary
Status:merged
FUNDING
Investors:Strides Pharma Science
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Sterile injectables
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:OneSource
Acquired By:OneSource (via strategic restructuring/merger) (2025-03-01)
Key Partnerships:Strides Pharma Science (Group entity), Brooks Laboratories (Majority stake acquired)
COMPETITION
Position:Niche Player
Competitors:Wockhardt Bio Pharma, Other global sterile injectable CDMOs
LEADERSHIP
Key Executives:
Arun Kumar - Promoter
LINKS
Website:steriscience.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Steriscience. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.